NCT05522491 2025-12-11
Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer
Hebei Medical University Fourth Hospital
Phase 2 Not yet recruiting
Clinical Trials
6 trialsNCT07258121 2025-12-02
Study of ZGGS34 in Participants With Advanced Solid Tumors
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2 Not yet recruiting
NCT07245901 2025-11-24
Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1/2 Not yet recruiting
NCT06895681 2025-11-10
UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations
University of California, San Francisco
Not yet recruiting
NCT07140393 2025-08-24
A Study of HRS-4508 in Combination With Other Anti-tumor Therapy for Solid Tumor
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2 Not yet recruiting
NCT06949761 2025-04-29
A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of QLC1101 in Combination With Other Therapies in the Treatment of Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting